Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus

Overview
TitleProduction of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus
AuthorsRout SS, de Grahl I, Yu X, Reumann S
TypeJournal Article
Journal NameApplied microbiology and biotechnology
Volume106
Issue19-20
Year2022
Page(s)6535-6549
CitationRout SS, de Grahl I, Yu X, Reumann S. Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus. Applied microbiology and biotechnology. 2022 Oct; 106(19-20):6535-6549.

Abstract

Nannochloropsis oceanica is a unicellular oleaginous microalga of emerging biotechnological interest with a sequenced, annotated genome, available transcriptomic and proteomic data, and well-established basic molecular tools for genetic engineering. To establish N. oceanica as a eukaryotic host for recombinant protein synthesis and develop molecular technology for vaccine production, we chose the viral surface protein 2 (VP2) of a pathogenic fish virus that causes infectious pancreatic necrosis as a model vaccine. Upon stable nuclear transformation of N. oceanica strain CCMP1779 with the codon-optimized VP2 gene, a Venus reporter fusion served to evaluate the strength of different endogenous promoters in transformant populations by qPCR and flow cytometry. The highest VP2 yields were achieved for the elongation factor promoter, with enhancer effects by its N-terminal leader sequence. Individual transformants differed in their production capability of reporter-free VP2 by orders of magnitude. When subjecting the best candidates to kinetic analyses of growth and VP2 production in photobioreactors, recombinant protein integrity was maintained until the early stationary growth phase, and a high yield of 4.4% VP2 of total soluble protein was achieved. The maximum yield correlated with multiple integrations of the expression vector into the nuclear genome. The results demonstrate that N. oceanica was successfully engineered to constitute a robust platform for high-level production of a model subunit vaccine. The molecular methodology established here can likely be adapted in a straightforward manner to the production of further vaccines in the same host, allowing their distribution to fish, vertebrates, or humans via a microalgae-containing diet. KEY POINTS: • We engineered N. oceanica for recombinant protein production. • The antigenic surface protein 2 of IPN virus could indeed be expressed in the host. • A high yield of 4.4% VP2 of total soluble protein was achieved in N. oceanica.

Properties
Additional details for this publication include:
Property NameValue
Journal CountryGermany
Publication TypeJournal Article
Language Abbreng
LanguageEnglish
Copyright© 2022. The Author(s).
Elocation10.1007/s00253-022-12106-7
DOI10.1007/s00253-022-12106-7
Journal AbbreviationAppl Microbiol Biotechnol
Publication Date2022 Oct
eISSN1432-0614
ISSN1432-0614
Publication ModelPrint-Electronic
Cross References
This publication is also available in the following databases:
DatabaseAccession
PMID: PubMedPMID:36069927